{
  "id": "b846296a4a125f0f",
  "title": "Quest Diagnostics CEO: Chronic Care Disease Management a Big Driver",
  "description": "Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in the lab testing industry. He tells Katie Greifeld and Scarlet Fu on \u201cThe Close\u201d that cancer testing accounts for about $1 billion of the company\u2019s $11 billion portfolio. (Source: Bloomberg)",
  "content": "Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in the lab testing industry. He tells Katie Greifeld and Scarlet Fu on \u201cThe Close\u201d that cancer testing accounts for about $1 billion of the company\u2019s $11 billion portfolio. (Source: Bloomberg)",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/videos/2026-02-10/davis-chronic-care-disease-management-a-big-driver-video",
  "published_at": "2026-02-10T22:01:46+00:00",
  "fetched_at": "2026-02-11T00:34:18.892628+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "Quest Diagnostics CEO: Chronic Care Disease Management a Big Driver",
    "description": "Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in the lab testing industry. He tells Katie Greifeld and Scarlet Fu on \u201cThe Close\u201d that cancer testing accounts for about $1 billion of the company\u2019s $11 billion portfolio. (Source: Bloomberg)",
    "url": "https://www.bloomberg.com/news/videos/2026-02-10/davis-chronic-care-disease-management-a-big-driver-video",
    "published": "2026-02-10T22:01:46+00:00",
    "source": "Bloomberg Markets"
  }
}